Vertex Pharmaceuticals Inc
VRTXCompany Overview
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
This stock meets all Shariah compliance criteria according to AAOIFI standards.
| Name | Vertex Pharmaceuticals Inc |
| Ticker | VRTX |
| Main Business | Biotechnology |
| Type | Common Stock |
| Industry | Biotechnology |
| Country | US |
| Market Cap | $104.79 B |
Shariah Analysis Breakdown
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| $8,930.7 | $0.0 | - | |
| Interest income | $144.6 | $144.6 | - |
| Total | $9,075.3 | $144.6 | 1.59% (passed) |
| Liability Item | Value ($M) | % of Market Cap |
|---|---|---|
| current debt and capital lease obligation | $83,700,000.0 | 0.08% |
| long term debt and capital lease obligation | $724,700,000.0 | 0.69% |
| Total Interest-Bearing Debt | $808,400,000.0 | 0.77% |
| Market Capitalization | $104,786,381,700.0 | 100.00% |
| Compliance Status | Threshold: 33% | passed |